News & Perspective

Sep 28, 2010

Sep 28, 2010

Experts cautiously optimistic on future impact of H1N1

(CIDRAP News) – With most Americans already possessing some degree of immunity to the 2009 H1N1 virus, the history of pandemics suggests that it's not very likely to make a big comeback anytime soon, according to three experts at the US National Institute of Allergy and Infectious Diseases (NIAID).

Aug 19, 2010

Aug 19, 2010

Obama's science advisors outline plan for faster pandemic vaccine

(CIDRAP News) – In light of vaccine production problems that delayed the delivery of the pandemic H1N1 vaccine, a report by President Barack Obama's science advisers released today said targeted investments in five specific areas could trim the time needed to quickly produce enough to protect the nation by weeks or months.

Aug 09, 2010

Aug 09, 2010

NIAID launches clinical trial of dengue vaccine

(CIDRAP News) – The National Institute of Allergy and Infectious Diseases (NIAID) has launched a clinical trial of a dengue virus vaccine, a product that eventually may help prevent a disease to which 2.5 billion people are exposed.

The launching of a trial at the Johns Hopkins Bloomberg School of Public in Baltimore and the University of Vermont in Burlington follows more than a decade of development, the NIAID said in a press release.

Jul 12, 2010

Jul 12, 2010

ICEID COVERAGE Experts air H1N1 lessons, other disease challenges

– ATLANTA (CIDRAP News) – The vital role of preparedness, from diagnostic testing to stockpiling of antiviral medications, was one of the most important lessons from assessments of the world's response to the H1N1 influenza pandemic, the World Health Organization's (WHO's) top flu expert told an international infectious diseases conference yesterday.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Gilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»